Braden Fenske - Net Worth and Insider Trading

Braden Fenske Net Worth

The estimated net worth of Braden Fenske is at least $826 dollars as of 2024-11-13. Braden Fenske is the Senior Officer of MediPharm Labs Corp and owns about 11,009 shares of MediPharm Labs Corp (TSX:LABS) stock worth over $826. Details can be seen in Braden Fenske's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Braden Fenske has not made any transactions after 2019-06-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Braden Fenske

To

Braden Fenske Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Braden Fenske owns 1 companies in total, including MediPharm Labs Corp (TSX:LABS) .

Click here to see the complete history of Braden Fenske’s form 4 insider trades.

Insider Ownership Summary of Braden Fenske

Ticker Comapny Transaction Date Type of Owner
TSX:LABS MediPharm Labs Corp 2019-06-20 Senior Officer

Braden Fenske Latest Holdings Summary

Braden Fenske currently owns a total of 1 stock. Braden Fenske owns 11,009 shares of MediPharm Labs Corp (TSX:LABS) as of June 20, 2019, with a value of $826.

Latest Holdings of Braden Fenske

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:LABS MediPharm Labs Corp 2019-06-20 11,009 0.08 826

Holding Weightings of Braden Fenske


Braden Fenske Form 4 Trading Tracker

According to the SEC Form 4 filings, Braden Fenske has made a total of 0 transactions in MediPharm Labs Corp (TSX:LABS) over the past 5 years. The most-recent trade in MediPharm Labs Corp is the acquisition of 2,000 shares on June 20, 2019, which cost Braden Fenske around $9,600.

Insider Trading History of Braden Fenske

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Braden Fenske Trading Performance

GuruFocus tracks the stock performance after each of Braden Fenske's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Braden Fenske is -2.26%. GuruFocus also compares Braden Fenske's trading performance to market benchmark return within the same time period. The performance of stocks bought by Braden Fenske within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Braden Fenske's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Braden Fenske

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.55 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 12.79 LIMIT LIMIT LIMIT LIMIT LIMIT

Braden Fenske Ownership Network

Ownership Network List of Braden Fenske

No Data

Ownership Network Relation of Braden Fenske

Insider Network Chart

Braden Fenske Owned Company Details

What does MediPharm Labs Corp do?

Who are the key executives at MediPharm Labs Corp?

Braden Fenske is the Senior Officer of MediPharm Labs Corp. Other key executives at MediPharm Labs Corp include Senior Officer Gregory Edison Hunter , Director & Senior Officer David Pidduck , and Director & Senior Officer Bryan Howcroft .

MediPharm Labs Corp (TSX:LABS) Insider Trades Summary

Over the past 18 months, Braden Fenske made no insider transaction in MediPharm Labs Corp (TSX:LABS). Other recent insider transactions involving MediPharm Labs Corp (TSX:LABS) include a net sale of 399,773 shares made by Keith Strachan , a net sale of 2,031,162 shares made by David Pidduck , and a net sale of 211,257 shares made by Gregory Edison Hunter .

In summary, during the past 3 months, insiders sold 0 shares of MediPharm Labs Corp (TSX:LABS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,642,192 shares of MediPharm Labs Corp (TSX:LABS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,642,192 shares.

MediPharm Labs Corp (TSX:LABS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

MediPharm Labs Corp Insider Transactions

No Available Data

Braden Fenske Mailing Address

Above is the net worth, insider trading, and ownership report for Braden Fenske. Currently GuruFocus does not have mailing address information for Braden Fenske.